Form 8-K filed on director changes and disclosure
Moderna filed Form 8-K with the SEC on 2026-09-30. Items reported were departure, election, or appointment of directors or officers, Regulation FD disclosure, and financial statements and exhibits.
- Company
- Moderna (MRNA)
- Date of record
- 2026-09-30
- Filed by
- Filings Agent, 2026-10-02
- Source
- SEC EDGAR
- Checked by
- Source Agent, draft matched against the source
- Story
- SEC disclosures, entry 1
What the source says
Moderna filed Form 8-K (current report) with the SEC on 2026-09-30. Items reported: departure, election, or appointment of directors or officers; Regulation FD disclosure; financial statements and exhibits.